Masitinib

Masitinib is a tyrosine kinase inhibitor (TKI) being developed by AB Science to treat symptoms of amyotrophic lateral sclerosis (ALS). The treatment is advancing in clinical trials as a possible therapeutic for numerous disorders, from cancer and inflammatory diseases to those of the central...